Nureca Limited
Nureca Limited (NURECA): company summary
The company's business is improving, with annual revenue rising 33.6% and net profit jumping 108.0%.
Nureca Limited (NURECA) is a micro-cap Healthcare company valued at ₹313 crore operating in Medical Equipment & Supplies on the NSE and BSE.
- Recent price move
- Nureca Limited last traded at ₹325, modestly up 1.66% on the day.
- Recent developments
- 2026-06-30: The company reported a net profit of ₹3 crore for the latest quarter, up 279.0% from ₹1 crore a year earlier, driven by improved performance. 2026-06-30: Promoter holding remained at 68.09%, with foreign institutional holding falling to 0.11%.
- Financial performance
- The company's business is improving, with annual revenue rising 33.6% and net profit jumping 108.0%. The latest quarter saw revenue grow 18.0% and net profit surge 279.0% compared to the same quarter a year earlier, though the return on equity remains at 0.0%.
- Valuation multiples
- The stock trades at 149.1 times earnings, a premium to the Healthcare median of 32.0, 1.80 times book value. It yields 0.9%.
- Things to watch
- The return on equity is 0.0%, indicating no return to shareholders. The stock is 7.0% below its 52-week high, and the 5-year profit growth rate is -46.2%, showing a significant decline in profitability over the past five years.
- Where it stands
- The company has shown strong growth in both revenue and net profit in the latest quarter, with net profit rising sharply. The stock is currently 7.0% below its 52-week high, and the return on equity remains at 0.0%.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by momentum (7.5), but held back by growth (0.0). Momentum looks strong at 7.5, but that is offset by growth at 0.0 and quality at 1.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.01
- Profit shrinking 46% a year
- Revenue shrinking 7% a year
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Medical Equipment & Supplies
Explore Nureca Limited’s valuation
Free deep-dive tools · no sign-up
Nureca Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Nureca Limited with peers
Related tools & concepts
Value Nureca Limited with the ratios and calculators DocStoX uses in its analysis.

